---

Laurent Grandidier

Chief Executive Officer, Xeltis

“Witnessing the first implant of our bioabsorbable technology in a child with congenital heart disease was truly remarkable,” says Laurent. “In that exact moment, our vision of a revolutionary approach to regenerative medicine, potentially transforming standards of care in cardiovascular treatment and allowing patients to live better lives, started becoming real.”

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016